WiserTogether and Elsevier Content Partnership Drives Informed Decision-Making
We strive to provide our users with trusted, high-quality content that they can rely on to make informed medical decisions. As part of our efforts to help users achieve better health outcomes, we are pleased to announce that Elsevier, a world-leading provider of scientific, technical and medical information products and services, is our latest content partner. Elsevier’s Gold Standard Drug Database will be added to WiserTogether’s suite of solutions, including Wiser Health.
The addition of Elsevier’s Gold Standard Drug Database content, which includes coverage of prescription, over-the-counter, and supplement drugs, will provide users with trusted information that they need to make better choices for their health. We will be able to offer Elsevier’s drug-specific content, such as drug interactions, adverse effects of medications, and medication images. The Gold Standard Drug Database is updated daily, ensuring that users will always have access to the most current and relevant drug information.
“Elsevier joins our growing list of content partners and allows us to continue adding high-quality content to our solution that better serves our clients and users,” said Shub Debgupta, CEO of WiserTogether. “Our partnership with Elsevier will support our vision to expand upon our coverage of treatments, ensuring that we are providing our users with the best and most current sources of drug information to make informed health decisions. ”
WiserTogether’s decision-making tools enable consumers to achieve better health outcomes and employers, health plans & payers to save money.